AstraZeneca and Lilly move Alzheimer's drug into big trial

LONDON, Dec 1 (Reuters) - AstraZeneca and Eli Lilly said on Monday they had started a large trial of their experimental Alzheimer's drug, seen as a promising, but still risky, approach for slowing the memory-robbing disease.